TCL Archive Supreme Court Decision Means FTC Scrutiny As Costly Oncology Drugs Go Off-Patent June 21, 2013
TCL Archive NCI Advisors Set SPORE Review Criteria, Approve Plan To Fund New Ovarian Grant June 26, 1998
TCL Archive Cancer Groups Urge FDA To Spell Out Standards For Data Collection In Time-To-Progression Trials. November 7, 2008
